Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials

INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for treatment of type 2 diabetes mellitus; however, there have been concerns that GLP-1RA treatment may be associated with an increased incidence of pancreatitis. This study aimed to evaluate the incidence of pancreat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Ther
Hlavní autoři: Vetter, Marion L., Johnsson, Kristina, Hardy, Elise, Wang, Hui, Iqbal, Nayyar
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6612359/
https://ncbi.nlm.nih.gov/pubmed/31077072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-0627-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky